Scientists will examine space conditions—especially how different levels of gravity affect antibiotic virulence and resistance.
Israeli researchers are sending a pioneering scientific mission to the International Space Station (ISS) this week to study how spaceflight alters the behavior of disease-causing bacteria.
The experiment, led by Sheba Medical Center’s innovation hub, ARC, and its Infectious Diseases Research Laboratory, is scheduled to launch Thursday aboard NASA and SpaceX’s Crew-11 mission from Kennedy Space Center in Florida.
Developed in partnership with U.S.-based space technology firm SpaceTango, the study will grow several bacterial species in microgravity while identical control samples remain on Earth.